Tilray, Inc.
(NASDAQ : TLRY)

( )
TLRY After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Process Industries » Agricultural Commodities Or Milling
symbolcompany%chnglast%shortavg$volume
ADMArcher-Daniels-Midland Co. 0.93%34.651.3%$156.00m
ELANElanco Animal Health, Inc. -2.74%20.200.0%$117.10m
TLRYTilray, Inc. -9.18%5.540.0%$89.30m
CGCCanopy Growth Corp. -4.20%13.220.0%$87.66m
BGBunge Ltd. -4.96%37.142.5%$70.79m
INGRIngredion, Inc. -1.06%76.282.7%$52.02m
CRONCronos Group, Inc. 1.85%5.520.0%$34.12m
DARDarling Ingredients, Inc. -2.03%17.411.4%$30.84m
ACBAurora Cannabis, Inc. -4.92%0.790.0%$29.29m
APHAAphria, Inc. -2.42%2.820.0%$13.91m
MGPIMGP Ingredients, Inc. -3.94%26.5613.5%$7.04m
OGIOrganiGram Holdings, Inc. -10.99%1.620.0%$6.42m
ANDEThe Andersons, Inc. 1.18%17.121.2%$4.88m
ELAT 0.45%37.740.0%$3.78m
AGROAdecoagro SA 1.69%3.620.2%$3.11m

Company Profile

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.